Pre-earnings options volume in INmune Bio (INMB) is normal with calls leading puts 10:7. Implied volatility suggests the market is anticipating a move near 14.9%, or 41c, after results are released. Median move over the past eight quarters is 2.6%.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INMB:
- INmune Bio Releases Video on Alzheimer’s Trial Results
- Largest borrow rate increases among liquid names
- INmune Bio announces video detailing findings from Phase 2 MINDFuL trial
- Inmune Bio Reveals Promising XPro™ Trial Results
- INmune Bio announces analyses from Phase 2 MINDFuL trial, endpoint not met